Polybiomics is pioneering advancements in live cell analysis through its innovative technology that allows for the simultaneous measurement of multiple cellular features from a single sample in real-time. This capability is facilitated by a proprietary process that integrates various data types, enabling the generation of deep, actionable insights that were previously unattainable. By leveraging this technology, Polybiomics accelerates discovery and product development in the pharmaceutical and clinical sectors, positioning itself as a leader in a rapidly growing market.

The company's live cell analysis platform is designed for drug discovery and development, utilizing a single instrument to conduct multimodal testing under consistent conditions. This integrated system not only enhances the efficiency of data collection but also employs artificial intelligence to derive actionable intelligence and predict outcomes. By doing so, Polybiomics aims to reduce costs, save time, and maintain the integrity of samples, thereby streamlining the research process and fostering innovation in the life sciences.

United States

Polybiomics is a biotechnology company that revolutionizes the analysis of live cells by enabling simultaneous measurements of multiple cellular features from the same sample in real-time, connecting data types to create actionable knowledge.

Polybiomics

Company Details